Check Biontech Se market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$23.6B
EPS (TTM)
-4.1059
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
-0.43%
PE Ratio (TTM)
-40.18
Industry PE ratio
16.65525641025641
P/B Ratio
0PEG Ratio
0.0449
EBITDA
-493.7M
Revenue (TTM)
2.9B
Profit Margin
-11.98%
Return On Equity TTM
7973300.00%
Track how Biontech Se P/E has moved over time to understand its valuation trends.
Biontech Se in the last 5 years
Lowest (3.38x)
June 30, 2022
Today (-40.18x)
September 18, 2025
Industry (16.66x)
September 18, 2025
Highest (26.31x)
December 31, 2023
Today’s Price to Earnings Ratio: -40.18x
Compare market cap, revenue, PE, and other key metrics of Biontech Se with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $23.6B | 46.49% | -40.18 | -11.98% | |
BUY | $60.5B | 241.54% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $99.3B | 45.88% | 27.56 | 31.86% | |
BUY | $60.9B | 5.45% | 14.49 | 31.37% |
The Biontech Se stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Biontech Se investment value today
Current value as on today
₹90,639
Returns
Returns from Biontech Se Stock
Dollar Returns*
₹4,953 (+4.95%)
Based on 24 analysts
54.17%
Buy
37.50%
Hold
8.33%
Sell
Based on 24 analysts, 54.17% of analysts recommend a 'BUY' rating for Biontech Se. Average target price of $137.12
Get share price movements and forecasts by analysts on Biontech Se.
What analysts predicted
27.75%UPSIDE
Target Price
$137.12
Current Price
$99.07
Analyzed by
24 Analysts
Target
$137.12
Biontech Se target price $137.12, a slight upside of 27.75% compared to current price of $99.07. According to 24 analysts rating.
Investment in Biontech Se Shares on INDmoney has grown by 860.00% over the past 30 days, indicating increased transactional activity.
Time period: to
Change:860.00% versus previous 30 day period
Search interest for Biontech Se Stock has increased by 169% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:169% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 12 September
Fri, 06:38 PM
-BioNTech and Bristol Myers present positive interim data for pumitamig in lung cancer treatment, showing high response rates.
Sat, 01:03 AM
-COVID-19 vaccine makers, including BioNTech, face declines amid reports linking vaccines to 25 child deaths, raising market concerns.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 2 quarters, -415.8M → -386.6M (in $), with an average increase of 7.6% per quarter
Revenue Rich
Revenue is up for the last 2 quarters, 182.8M → 260.8M (in $), with an average increase of 29.9% per quarter
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 144.2%
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 83.5%
Price Dip
In the last 1 month, BNTX stock has moved down by -12.8%
Organisation | Biontech Se |
Headquarters | An der Goldgrube 12, Mainz, Germany, 55131 |
Industry | Health Technology |
CEO | Dr. Ugur Sahin M.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Dr. Sierk Poetting Ph.D. | MD, COO & Member of Management Board |
Ms. Annemarie Hanekamp | Chief Commercial Officer & Member of Management Board |
Mr. Ramón Zapata-Gomez | CFO & Member of Management Board |
Ms. Beate Berns | Senior Vice President of Global Human Resources |
Dr. Ugur Sahin M.D. | Co-Founder, CEO & Chair of the Management Board |
Dr. Ozlem Tureci M.D. | Co-Founder, Chief Medical Officer & Member of Management Board |
Mr. Ryan Richardson | Chief Strategy Officer, MD & Member of Management Board |
Dr. James Timothy Patrick Ryan Ph.D. | Chief Legal & Business Officer & Member of the Management Board |
Ms. Lisa Birringer | Senior Vice President of Global Financial Reporting & Accounting |
Dr. Oliver Henning Ph.D. | Senior Vice President of Operations |
Biontech Se share price today is $99.07 as on . Biontech Se share today touched a day high of $99.49 and a low of $98.2.
Biontech Se share touched a 52 week high of $129.27 on and a 52 week low of $81.2 on . Biontech Se stock price today i.e. is trending at $99.07,which is 23.36% down from its 52 week high and 22.01% up from its 52 week low.
Biontech Se market capitalisation is $0.02T as on .
Indian investors can start investing in Biontech Se (BNTX) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Biontech Se stock (as per the Rupee-Dollar exchange rate as on ).
Based on Biontech Se share’s latest price of $99.07 as on September 18, 2025 at 8:37 pm IST, you will get 0.1009 shares of Biontech Se. Learn more about
fractional shares .
Biontech Se stock has given 46.49% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?